Title: Cragoe Jr., Edward J, et al. 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione compounds, process for their preparation and pharmaceutical compositions containing the same.EP0021228A1.
757251-62-0 | 4-Chloro-N-methoxy-N-methylpyridine-2-carboxamide | AA008PG7 | MFCD11975556
754193-08-3 | N-(4-Amino-2-chlorophenyl)propanamide | AA008Q19 | MFCD03906866
752231-43-9 | Ethyl 2-chloro-5-(5-formyl-2-furyl)benzoate | AA008QRN | MFCD01158422
111247-60-0 | 1-Pyrimidin-2-yl-piperidine-4-carboxylic acid ethyl ester | AA008R5B | MFCD01456221
104723-60-6 | 6-O-α-Maltosyl-β-cyclodextrin | AA008RGO | MFCD00671560
105362-06-9 | 4-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-thiazol-2-ylamine | AA008RNE | MFCD00807205
1006458-74-7 | [(3,5-Dimethyl-1-propyl-1h-pyrazol-4-yl)methyl]amine hydrochloride | AA008RVN | MFCD13857384
1072945-09-5 | 2-Methylthiophenylboronic acid, pinacol ester | AA008S48 | MFCD05155219
1033906-44-3 | 3,3,3-Trifluoropropane-1-sulfonamide | AA008SD0 | MFCD08704575
118802-40-7 | 4-Chloro-2-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidine | AA008SKD | MFCD14648013